Autek China Inc.

SZSE:300595 Stock Report

Market Cap: CN¥17.5b

Autek China Valuation

Is 300595 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300595 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300595 (CN¥19.73) is trading below our estimate of fair value (CN¥25.44)

Significantly Below Fair Value: 300595 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300595?

Key metric: As 300595 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 300595. This is calculated by dividing 300595's market cap by their current earnings.
What is 300595's PE Ratio?
PE Ratio27.2x
EarningsCN¥651.13m
Market CapCN¥17.49b

Price to Earnings Ratio vs Peers

How does 300595's PE Ratio compare to its peers?

The above table shows the PE ratio for 300595 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21.4x
600529 Shandong Pharmaceutical GlassLtd
19.1x18.4%CN¥16.8b
688029 Micro-Tech (Nanjing)Ltd
25.3x19.0%CN¥13.7b
301371 Harbin Fuerjia Technology
19.9x8.4%CN¥14.5b
603658 Autobio Diagnostics
21.1x20.3%CN¥26.5b
300595 Autek China
27.2x16.8%CN¥17.5b

Price-To-Earnings vs Peers: 300595 is expensive based on its Price-To-Earnings Ratio (27.2x) compared to the peer average (21.4x).

Price to Earnings Ratio vs Industry

How does 300595's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
300595 27.2xIndustry Avg. 36.1xNo. of Companies14PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 300595 is good value based on its Price-To-Earnings Ratio (27.2x) compared to the CN Medical Equipment industry average (36.1x).

Price to Earnings Ratio vs Fair Ratio

What is 300595's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300595 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio27.2x
Fair PE Ratio26.9x

Price-To-Earnings vs Fair Ratio: 300595 is expensive based on its Price-To-Earnings Ratio (27.2x) compared to the estimated Fair Price-To-Earnings Ratio (26.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 300595 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥19.73
CN¥20.93
+6.1%
16.2%CN¥26.70CN¥17.75n/a5
Nov ’25CN¥18.32
CN¥21.56
+17.7%
15.8%CN¥26.70CN¥17.75n/a6
Oct ’25CN¥20.72
CN¥21.93
+5.8%
14.1%CN¥26.70CN¥18.00n/a6
Sep ’25CN¥14.39
CN¥22.93
+59.3%
11.2%CN¥26.70CN¥19.40n/a6
Aug ’25CN¥16.15
CN¥23.83
+47.5%
11.5%CN¥29.00CN¥19.96n/a6
Jul ’25CN¥15.78
CN¥22.78
+44.4%
15.9%CN¥29.00CN¥16.50n/a7
Jun ’25CN¥17.95
CN¥24.85
+38.5%
14.4%CN¥31.00CN¥19.96n/a7
May ’25CN¥18.83
CN¥24.85
+32.0%
14.4%CN¥31.00CN¥19.96n/a7
Apr ’25CN¥18.75
CN¥29.72
+58.5%
22.6%CN¥43.00CN¥22.16n/a7
Mar ’25CN¥20.60
CN¥31.24
+51.7%
17.7%CN¥43.00CN¥25.69n/a7
Feb ’25CN¥17.47
CN¥31.24
+78.8%
17.7%CN¥43.00CN¥25.69n/a7
Jan ’25CN¥22.58
CN¥31.99
+41.7%
16.7%CN¥43.00CN¥25.69n/a7
Dec ’24CN¥24.44
CN¥31.99
+30.9%
16.7%CN¥43.00CN¥25.69n/a7
Nov ’24CN¥25.01
CN¥32.92
+31.6%
15.8%CN¥43.00CN¥25.69CN¥18.326
Oct ’24CN¥25.68
CN¥39.83
+55.1%
21.8%CN¥53.00CN¥30.19CN¥20.726
Sep ’24CN¥26.43
CN¥41.00
+55.1%
22.1%CN¥53.00CN¥30.19CN¥14.395
Aug ’24CN¥34.03
CN¥44.77
+31.5%
25.7%CN¥58.00CN¥31.00CN¥16.155
Jul ’24CN¥30.19
CN¥44.77
+48.3%
25.7%CN¥58.00CN¥31.00CN¥15.785
Jun ’24CN¥28.14
CN¥44.77
+59.1%
25.7%CN¥58.00CN¥31.00CN¥17.955
May ’24CN¥32.37
CN¥48.07
+48.5%
19.2%CN¥58.00CN¥33.83CN¥18.835
Apr ’24CN¥33.12
CN¥53.46
+61.4%
21.4%CN¥70.20CN¥37.60CN¥18.755
Mar ’24CN¥34.34
CN¥52.97
+54.2%
19.8%CN¥70.20CN¥37.60CN¥20.606
Feb ’24CN¥37.83
CN¥52.97
+40.0%
19.8%CN¥70.20CN¥37.60CN¥17.476
Jan ’24CN¥35.70
CN¥56.04
+57.0%
15.5%CN¥70.20CN¥47.50CN¥22.585
Dec ’23CN¥32.21
CN¥56.04
+74.0%
15.5%CN¥70.20CN¥47.50CN¥24.445
Nov ’23CN¥30.96
CN¥56.04
+81.0%
15.5%CN¥70.20CN¥47.50CN¥25.015

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥7.1b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥16.71

7D

-4.2%

1Y

-27.4%

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥42.13

7D

-4.5%

1Y

64.8%

Winner Medical

CN¥20.0b

Engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China.

300888

CN¥34.29

7D

3.7%

1Y

-13.6%